Pancreatic Cancer Research

ResearcherUniversité Paris CitéActive in the last 2 years

Lina Aguilera Munoz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6317-8725; OpenAlex author ID A5054531510. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review). Last author DOI 10.3892/ijo.2026.5848↗
  2. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens. First author DOI 10.1177/17588359231163776↗
  3. Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments. Co-author DOI 10.1177/2050640620939788↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sophie Rauschenberg · 1 shared paper, 2026 · strength 0.32
  2. Ivonne Regel · 1 shared paper, 2026 · strength 0.32
  3. Matthias J. Löhr · 1 shared paper, 2026 · strength 0.32
  4. Daniel Öhlund · 1 shared paper, 2026 · strength 0.32
  5. Vinciane Rebours · 2 shared papers, 2020–2023 · strength 0.28
  6. Louis de Mestier · 2 shared papers, 2020–2023 · strength 0.28
  7. Pascal R. Hammel · 2 shared papers, 2020–2023 · strength 0.28
  8. Thomas Chaigneau · 1 shared paper, 2023 · strength 0.16
  9. Olivia Hentic Dhome · 1 shared paper, 2023 · strength 0.16
  10. Frédérique Maire · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.